Medicine
Economy
[Big read] China has the drugs. Can it build the next Pfizer?
Chinese pharmaceutical companies are moving from licensing to big pharma to building their own R&D, manufacturing and sales ecosystem overseas. Lianhe Zaobao China news correspondent Lim Zhan Ting speaks with industry insiders to find out how China managed to catch up.
Lim Zhan Ting
09 Oct 2026
Economy
[Big read] Big Pharma bets billions on China biotech — will Washington pull the plug?
Western drugmakers are pouring billions into China’s fast-growing biotech sector, but the US’s push to scrutinise outbound investment could put one of the few thriving areas of US-China cooperation at risk. Lianhe Zaobao’s senior foreign correspondent Pang Kia Nian finds out more.
Pang Kia Nian
25 Sep 2026
Society
[Vox pop] Why ‘light medical aesthetics’ are going mainstream in China
Cheaper and safer than plastic surgery, light medical aesthetics are increasingly accepted in China by women and men alike, reflecting a shared desire for subtle enhancement. ThinkChina’s Yi Jina finds out more.
Yi Jina
23 Sep 2026
Economy
[Big read] Is Singapore the ultimate ‘China+1’ biopharma hub?
China’s biotech industry is becoming a formidable force in drug R&D and manufacturing. For Singapore, its rise brings new competition — but also an opportunity to strengthen its role as a trusted China+1 hub for global pharma. Lianhe Zaobao senior business correspondent Lewis Ong Yong Huat speaks with industry players and government officials to find out more.
Lewis Ong Yong Huat
09 Sep 2026
Economy
Why China’s biotech rise is harder to contain than AI
China is emerging as a biotech powerhouse, but its rise is entwined with US drugmakers through research, licensing and supply chains, making decoupling far more difficult than in AI. Academic Chen Xiangming and biopharma industry practitioner Leon Tang analyse the situation.
Chen Xiangming, Leon Tang
05 Aug 2026
Society
[Video] Effortlessly beautiful: China’s new obsession with ‘invisible’ cosmetic procedures
Why are millions of Chinese paying for cosmetic procedures that nobody is supposed to notice? The pursuit of “natural beauty” is reshaping the country’s booming medical aesthetics industry. ThinkChina’s Yi Jina finds out more.
Yi Jina
31 Jul 2026
Technology
US’s biotech scrutiny tests China’s drugmakers abroad
A proposed US bill to tighten scrutiny of biotech investment in China is casting a shadow over cross-border drug licensing, threatening a fast-growing partnership model that has fuelled innovation and global drug development.
Caixin Global
10 Jul 2026
Economy
China’s bid for a slice of the medical tourism market
Driven by vast surgical experience and lower costs, China’s medical tourism sector is expanding. However, Lianhe Zaobao correspondent Yush Chau finds out that building an international reputation and managing domestic resources remain key challenges.
Yush Chau
02 Jun 2026
Society
[Big read] China’s ‘fur kids’ fuel a billion-dollar pet boom
China’s growing love for pets has created a billion-dollar industry, with smart devices, AI services and full life-cycle care. Local governments are also backing the trend to boost domestic consumption. Lianhe Zaobao journalist Zeng Shi speaks to industry players to find out more about the shift in social attitudes and policies that have led to this growth.
Zeng Shi
30 Mar 2026
Society
Tu Zhiliang: The man who believes Chinese medicine can save the world
Just as Chinese restaurants thrive wherever there is an ethnic Chinese community, Gu Sheng Tang TCM CEO Tu Zhiliang wants the same for TCM services. Lianhe Zaobao senior lifestyle correspondent Dennis Ng speaks to the wuxia fan with a vision of saving the world through traditional Chinese medicine.
Dennis Ng
11 Mar 2026
